Please i want this answer within 30 mintues i am posting this for third time.

Kane Biotech was preparing the annual financial statements and, as part of the year-end procedures, assessed the assets and prepared the following alphabetized schedule based on adjusted values at December 31, 2023: (Do not round intermediate calculations. Round final answers to nearest whole dollar.) Equipment Furniture Land office building Warehouse Date of Purchase May 1/18 Jun. 28/18 You received partial credit in the previous attempt. Apr. 5/18 Apr. 5/18 Apr. 5/18 Deprec. Method* Cost Units $ 65,000 DDB N/A SL SL 32,000 105,000 117,000 85,000 Residual Value $ 2,000 4,000 N/A 35,000 30,000 Useful Life 9,000 units 8 yrs N/A - 15 yrs 20 yrs Accum. Deprec. $ 42,000 26,909 N/A 41,000 32,938 View previous attempt Recoverable Amount $ 5,000 6,050 121,800 72,500 65,100 *DDB = Double-declining-balance, SL = Straight-line; Units Units-of-production; N/A = Not applicable Required: 1. Record any impairment losses at December 31, 2023. Assume Kane Biotech has recorded no impairment losses in previous years.

- You received partial credit in the previous attempt Kane Biotech was preparing the annual financial statements and, as part of the year-end procedures, assessed the assets and prepared the following alphabetized schedule based on adjusted values at December 31, 2023. (Do not round intermediate calculations. Round final answers to nearest whole dollar.) "DOB = Double declining bolance, St - Straight-line; Units = Units-of-production; N/A= Not applicable Required: 1. Record any impairment losses at December 31, 2023 Assume Kane Biotech has recorded no impairment losses in previous years. 2. Record depreciation for eoch asset at Docember 31 2024. Assume that there was no change in the residual values or useful lives regardless of any imparment losses that might have occurred The equipment produced 2,800 units during 2024